Results 291 to 300 of about 463,990 (330)
Correction: Zavestovskaya et al. Boron Nanoparticle-Enhanced Proton Therapy for Cancer Treatment. <i>Nanomaterials</i> 2023, <i>13</i>, 2167. [PDF]
Zavestovskaya IN +16 more
europepmc +1 more source
ROS‐Triggered Microgels for Programmable Drug Release in Volumetric Muscle Loss Repair
Reduced graphene oxide‐incorporated hyaluronic acid microgels are developed as ROS‐responsive, injectable platforms for curcumin delivery in volumetric muscle loss. The microgels exhibit strong antioxidative activity, high drug‐loading capacity, and ROS‐triggered release.
Seungjun Lee +5 more
wiley +1 more source
Recent Progress of Magnetic Nanomaterials with Enhanced Enzymatic Activities in Antitumor Therapy. [PDF]
Zhang Y +8 more
europepmc +1 more source
Hybrid wrinkled topographies coordinate immune, tissue, and bacterial interactions. The surfaces promote osteointegration, tune macrophage polarization, and inhibit biofilm formation, highlighting a multifunctional strategy for next‐generation implant design.
Mohammad Asadi Tokmedash +4 more
wiley +1 more source
Current status of using adsorbent nanomaterials for removing microplastics from water supply systems: a mini review. [PDF]
Nhan NT, Luu TL.
europepmc +1 more source
This work presents a novel, dynamically perfused, configurable microfluidic system for epidermis‐only (E and full‐thickness skin (FT SoC) growth, emulating human skin structure and barrier function. Upon TiO2 nanoparticle exposure, the system reveals compromised barrier integrity, reduced metabolic activity, increased permeability, and chemokine‐driven
Samantha Costa +7 more
wiley +1 more source
RETRACTED: Sabeela et al. Reactive Mesoporous pH-Sensitive Amino-Functionalized Silica Nanoparticles for Efficient Removal of Coomassie Blue Dye. <i>Nanomaterials</i> 2019, <i>9</i>, 1721. [PDF]
Sabeela NI +4 more
europepmc +1 more source
This study develops cyclic peptidepolymer conjugate nanotubes with hydrophobic, drug‐rich cores to enhance drug loading and stability, and demonstrates their responsive disassembly, pharmacokinetics, and anti‐tumour efficacy in colorectal cancer models using the anticancer drug SN‐38.
Sophie K. Hill +4 more
wiley +1 more source

